James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 236,280 shares at $7.97 ($1.7M) on 2018-06-13, disclosed to the SEC on 2018-06-14.
Open-market sale of $1.7M GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.59 | 60,000 | $395K | 23.0% |
| 2 | $7.09 | 60,000 | $425K | 24.8% |
| 3 | $7.47 | 60,000 | $448K | 26.1% |
| 4 | $7.97 | 28,140 | $224K | 13.1% |
| 5 | $7.97 | 28,140 | $224K | 13.1% |
| Total | $7.27 avg | 236,280 |
| $1.7M |
| 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |